引用本文:[点击复制]
[点击复制]
【打印本页】 【在线阅读全文】【下载PDF全文】 查看/发表评论下载PDF阅读器关闭

←前一篇|后一篇→

过刊浏览    高级检索

本文已被:浏览 431次   下载 146 本文二维码信息
码上扫一扫!
儿童人群替加环素不良反应主动监测与风险因素分析
李桂凤,颜颖慧,王凤娇,姚华,薛进,朱增燕
0
(苏州大学附属儿童医院,江苏苏州 215001)
摘要:
目的:对儿童使用替加环素发生不良反应(ADR)进行主动监测与风险因素评估。方法:通过医院信息系统(HIS)抽取我 院2023-2024 年使用替加环素的患儿信息、药物信息、用药前后的检验结果等进行ADR 主动监测,建立多因素回归模型探索替 加环素所致ADR 的风险因素。结果:我院2023-2024 年共有237 例患儿使用替加环素,其中85 例(35. 86%) 在替加环素应用 期间发生ADR。发生ADR 组和未发生ADR 组的替加环素用药疗程、是否合并血液系统疾病、是否联用抗肿瘤药物情况比较差 异有统计学意义(P<0. 05);进一步二元logistic 回归分析显示,替加环素用药疗程>7 d 和联用抗肿瘤药物是发生替加环素相关 ADR 的危险因素。结论:真实世界中,替加环素ADR 主动监测的儿童人群应为替加环素用药疗程>7 d,尤其是诊断血液系统疾 病且有可能联用抗肿瘤药物的患儿。
关键词:  替加环素  药品不良反应  主动监测  风险因素  医院信息系统  儿童
DOI:doi:10.13407/j.cnki.jpp.1672-108X.2025.11.014
基金项目:
Active Monitoring and Risk Factor Analysis of Tigecycline Adverse Drug Reactions in the PediatricPopulation
Li Guifeng, Yan Yinghui, Wang Fengjiao, Yao Hua, Xue Jin, Zhu Zengyan
(Children’s Hospital of Soochow University, Jiangsu Suzhou 215001, China)
Abstract:
Objective: To perform active monitoring and risk factor assessment of adverse drug reactions (ADR) associated with tigecycline in children. Methods: The data on children administered tigecycline from 2023 to 2024 were extracted from the hospital information system (HIS), including general information, drug details, and laboratory results before and after administration. A multivariate regression model was established to assess risk factors for tigecycline-induced ADR. Results: A total of 237 children were treated with tigecycline in our hospital from 2023 to 2024, and 85 cases (35. 86%) developed ADR during tigecycline treatment. Significant differences were observed in tigecycline treatment course, presence of hematologic diseases, and combined use of anti-tumor drugs (P<0. 05). Further binary logistic regression analysis revealed that treatment course >7 d with tigecycline and the combined use of anti-tumor drugs were risk factors for tigecycline-induced ADR. Conclusion: In the real world, pediatric patients receiving tigecycline for >7 d, particularly those diagnosed with hematologic diseases and potentially requiring anti-tumor drugs should be prioritized for active ADR monitoring.
Key words:  tigecycline  adverse drug reactions  active monitoring  risk factors  hospital information system  children

用微信扫一扫

用微信扫一扫